PDCD1 and neoplasm: Indeed, although VEGFR inhibitors induce the expression of PD-L1 on tumor cells, combination of anti-PD-1/PD-L1 antibody and VEGFR inhibitor exhibited greater antitumor activity than either treatment alone24.